Skip to main content

Table 3 Molecular subtypes

From: Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya

Variable Characteristics N (%)
Luminal A ER+ and/or PR+, HER2−, low Ki-67 7 (14)
Luminal B ER+ and/or PR+, HER2+ (or HER2− with high Ki-67) 20 (41)
Her2 ER− and/or PR-, Her2 + Any Ki-67 4 (8)
Basal/triple negative ER−, PR−, HER2− and any Ki-67 18 (37)
  1. ER+/- estrogen receptor positive or negative, PR+/- progesterone receptor positive or negative, HER2 +/- human epidermal growth factor positive or negative